Organigram Announces Resignation of Board Member
01 Setembro 2023 - 7:00PM
Business Wire
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the
“Company” or “Organigram”), a leading licensed producer of
cannabis, announces today that Ms. Caroline Ferland has resigned
from the Board of Directors (“the Board”) effective immediately.
Ms. Ferland was a board member nominee appointed by BAT.
“In her short time on the Board, Ms. Ferland made considerable
contributions to Organigram,” said Peter Amirault, Chair of
Organigram’s Board of Directors. “In addition to providing
meaningful involvement on the strategic planning and corporate
governance fronts, Ms. Ferland used her extensive international
experience in legal and regulatory matters to support the Company,
providing solid strategic guidance on several matters.”
Ms. Ferland is leaving Organigram’s Board of Directors as a
result of her appointment to Group Company Secretary &
Assistant General Counsel for BAT, based in the UK. The Board of
Directors and the Company’s management team would like to thank Ms.
Ferland for her valuable contributions to Organigram and wish her
well in her new role.
BAT has informed Organigram that it expects to appoint a
replacement nominee in due course Simon Ashton continues to serve
on the Board as one of BATs two contractual nominees.
About Organigram Holdings Inc. Organigram Holdings Inc.
is a NASDAQ Global Select Market and TSX listed company whose
wholly owned subsidiaries include: Organigram Inc. and Laurentian
Organic Inc., licensed producers of cannabis and cannabis-derived
products in Canada, and The Edibles and Infusions Corporation, a
licensed manufacturer of cannabis-infused edibles in Canada.
Organigram is focused on producing high-quality, cannabis for
patients and adult recreational consumers, as well as developing
international business partnerships to extend the Company’s global
footprint. Organigram has also developed and acquired a portfolio
of legal adult-use recreational cannabis brands, including Edison,
Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour,
Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates
facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec,
with a dedicated edibles manufacturing facility in Winnipeg,
Manitoba. The Company is regulated by the Cannabis Act and the
Cannabis Regulations (Canada).
Forward-Looking Information This news release contains
forward-looking information. Often, but not always, forward-looking
information can be identified by the use of words such as “plans”,
“expects”, “estimates”, “intends”, “anticipates”, “believes” or
variations of such words and phrases or state that certain actions,
events, or results “may”, “could”, “would”, “might” or “will” be
taken, occur or be achieved. Forward-looking information involves
known and unknown risks, uncertainties and other factors that may
cause actual results, events, performance or achievements of
Organigram to differ materially from current expectations or future
results, performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors and risks as disclosed in the Company’s most recent annual
information form, management’s discussion and analysis and other
Company documents filed from time to time on SEDAR (see
www.sedar.com) and filed or furnished to the Securities and
Exchange Commission on EDGAR (see www.sec.gov). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230901843035/en/
For Investor Relations enquiries: Max Schwartz
Director of Investor Relations investors@organigram.ca
Organigram
For Media enquiries: Megan McCrae Senior Vice
President of Marketing and Communications
megan.mccrae@organigram.ca Organigram
Organigram (NASDAQ:OGI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Organigram (NASDAQ:OGI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024